BEAMTREE HOLDINGS LIMITED (BMT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BMT - BEAMTREE HOLDINGS LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.36
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.235

30 Nov
2023

-0.005

OPEN

$0.24

-2.08%

HIGH

$0.24

27,311

LOW

$0.24

TARGET
$0.70 197.9% upside
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . ALC . CAJ . DOC . EBO . HLA . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL . SLA .
FNARENA'S MARKET CONSENSUS FORECASTS
BMT: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx - 2.8 - 1.5 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-2.8
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx22.8 M
Book Value Per Share xxxxxxxxxxxxxxx17.7
Net Operating Cash Flow xxxxxxxxxxxxxxx0.8 M
Net Profit Margin xxxxxxxxxxxxxxx-30.34 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-14.42 %
Return on Invested Capital xxxxxxxxxxxxxxx-14.23 %
Return on Assets xxxxxxxxxxxxxxx-10.93 %
Return on Equity xxxxxxxxxxxxxxx-14.42 %
Return on Total Capital xxxxxxxxxxxxxxx-14.36 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx0.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx1 M
Goodwill - Gross xxxxxxxxxxxxxxx31 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx9 M
Price To Book Value xxxxxxxxxxxxxxx1.32

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx2.7 M
Capex % of Sales xxxxxxxxxxxxxxx11.64 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx25 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

30/10/2023

1

Buy

$0.70

197.87%

Beamtree Holdings' first quarter update outlined a solid start to the financial year, according to Shaw and Partners, with revenue up 23% year-on-year and tracking ahead of full year guidance. 

The broker pointed out momentum appears to be building in Abbott, with the company securing three new smaller licenses and a second larger revenue share deal in the period, in addition to four existing customers renewing on new pricing terms. 

The company also announced a collaborative agreement with Lean to develop a next generation coding platform for Abbott, in a bid to leverage existing products and target global markets.

The Buy rating and target price of 70 cents are retained.

FORECAST
Shaw and Partners forecasts a full year FY24 dividend of 0.00 cents and EPS of minus -1.50 cents.
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -1.20 cents.
Access Stockbroker Research History >

BMT STOCK CHART

FNArena News on BMT

1
Australian Broker Call *Extra* Edition – Nov 06, 2023

Nov 06 2023 - Daily Market Reports
2
FNArena Corporate Results Monitor – 25-08-2023

Aug 25 2023 - Australia
3
Australian Broker Call *Extra* Edition – Aug 04, 2023

Aug 04 2023 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Jun 01, 2023

Jun 01 2023 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Feb 23, 2023

Feb 23 2023 - Daily Market Reports

Latest Healthcare services News

1
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
2
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
3
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
4
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
5
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
6
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps
7
Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022 - Small Caps
8
Healius Offers Digital Carrot, Base Remains Soft

May 25 2022 - Australia
9
Ramsay Stakes Future on Mental Health

Dec 20 2021 - Australia
10
Ramsay Health Care: Finally A Break-Out

Nov 09 2021 - Technicals